Concerning the DMD geno- and phenotypes, DMD-iPS1 and DMD-iPS2 (CHB, Boston, MA, USA) were induced in a 6-year-old male patient with an identified deletion of exon45-52 of the dystrophin gene and a clinical DMD phenotype, while DMD3 (UCSD061i-65-1) (UCSD, San Diego, CA, USA) was induced in a 23-year-old male patient with an undisclosed dystrophin mutation, clinical DMD, and a dilated cardiomyopathy phenotype. This evidence concerns the gene DMD and dilated cardiomyopathy.